Publications by authors named "Mary V Graham"

Claim this Profile
M
Modeling the risk of radiation-induced acute esophagitis for combined Washington University and RTOG trial 93-11 lung cancer patients.
Ellen X Huang, Jeffrey D Bradley, Issam El Naqa, Andrew J Hope, Patricia E Lindsay, Mary V Graham

Int J Radiat Oncol Biol Phys· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117.
Jeffrey D Bradley, Jennifer Moughan, Mary V Graham, Roger Byhardt, Ramaswamy Govindan

Int J Radiat Oncol Biol Phys· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117.
Jeffrey D Bradley, Kyounghwa Bae, Mary V Graham, Roger Byhardt, Ramaswamy Govindan

J Clin Oncol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data.
Jeffrey D Bradley, Andrew Hope, Issam El Naqa, Aditya Apte, Patricia E Lindsay, Mary V Graham

Int J Radiat Oncol Biol Phys· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.
Jeffrey D Bradley, Rebecca Paulus, Mary V Graham, David S Ettinger, David W Johnstone

J Clin Oncol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
Jeffrey Bradley, Mary V Graham, Kathryn Winter, James A Purdy, Ritsuko Komaki

Int J Radiat Oncol Biol Phys· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung cancer: an analysis of RTOG data.
Bahman Emami, Nena Mirkovic, Charles Scott, Roger Byhardt, Mary V Graham

Lung Cancer· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma.
Jeffrey D Bradley, Nantaken Ieumwananonthachai, James A Purdy, Todd H Wasserman, Mary Ann Lockett, Mary V Graham

Int J Radiat Oncol Biol Phys· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis